GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Incannex Healthcare Ltd (ASX:IHL) » Definitions » LT-Debt-to-Total-Asset

Incannex Healthcare (ASX:IHL) LT-Debt-to-Total-Asset : 0.01 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Incannex Healthcare LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Incannex Healthcare's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.01.

Incannex Healthcare's long-term debt to total assets ratio increased from Dec. 2022 (0.00) to Dec. 2023 (0.01). It may suggest that Incannex Healthcare is progressively becoming more dependent on debt to grow their business.


Incannex Healthcare LT-Debt-to-Total-Asset Historical Data

The historical data trend for Incannex Healthcare's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incannex Healthcare LT-Debt-to-Total-Asset Chart

Incannex Healthcare Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Incannex Healthcare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.01 - 0.01

Incannex Healthcare LT-Debt-to-Total-Asset Calculation

Incannex Healthcare's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2022 is calculated as

LT Debt to Total Assets (A: Jun. 2022 )=Long-Term Debt & Capital Lease Obligation (A: Jun. 2022 )/Total Assets (A: Jun. 2022 )
=0/37.081
=

Incannex Healthcare's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )/Total Assets (Q: Dec. 2023 )
=0.45/33.404
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Incannex Healthcare  (ASX:IHL) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Incannex Healthcare LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Incannex Healthcare's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Incannex Healthcare (ASX:IHL) Business Description

Traded in Other Exchanges
Address
8 Century Circuit Norwest, Suite 105, Sydney, NSW, AUS, 3000
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.

Incannex Healthcare (ASX:IHL) Headlines

No Headlines